These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 5425288
21. Occurrence of deaminated monophosphate nucleotide in extracellular sites after giving arabinofuranosylcytosine or deoxycytidine to mice. Chou TC, Hutchison DJ, Schmid FA, Philips FS. Ann N Y Acad Sci; 1975 Aug 08; 255():287-91. PubMed ID: 1059362 [No Abstract] [Full Text] [Related]
22. Enzymatic estimation and metabolism of 1- -D-arabinofuranosylcytosine in man. Momparler RL, Labitan A, Rossi M. Cancer Res; 1972 Feb 08; 32(2):408-12. PubMed ID: 4500684 [No Abstract] [Full Text] [Related]
23. Transport of two non-metabolized nucleosides, deoxycytidine and cytosine arabinoside, in a sub-line of the L1210 murine leukemia. Kessel D, Shurin SB. Biochim Biophys Acta; 1968 Sep 17; 163(2):179-87. PubMed ID: 5686275 [No Abstract] [Full Text] [Related]
24. Antileukemic activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine, a new depot form of 1-beta-D-arabinofuranosylcytosine. Khwaja TA, Kigwana LJ, Mian AM. Cancer Res; 1979 Aug 17; 39(8):3129-33. PubMed ID: 455296 [No Abstract] [Full Text] [Related]
34. Metabolism of 1-beta-D-arabinofuranosylcytosine in L cells. Silagi S. Cancer Res; 1965 Oct 17; 25(9):1446-53. PubMed ID: 5861073 [No Abstract] [Full Text] [Related]
35. Inability of liposome encapsulated 1-beta-D-arabinofuranosylcytosine nucleotides to overcome drug resistance in L1210 cells. Rustum YM, Mayhew E, Szoka F, Campbell J. Eur J Cancer Clin Oncol; 1981 Jul 17; 17(7):809-17. PubMed ID: 7199474 [No Abstract] [Full Text] [Related]
36. Kinetics of effect of 1-beta-D-arabinofuranosylcytosine, its 5'-palmitoyl ester, 1-beta-D-arabinofuranosyluracil, and tritiated thymidine on the viability of cultured leukemia L1210 cells. Wilkoff LJ, Dulmadge EA, Lloyd HH. J Natl Cancer Inst; 1972 Mar 17; 48(3):685-95. PubMed ID: 5058968 [No Abstract] [Full Text] [Related]
37. Properties of deoxycytidine kinase partially purified from L1210 cells. Kessel D. J Biol Chem; 1968 Sep 25; 243(18):4739-44. PubMed ID: 5687717 [No Abstract] [Full Text] [Related]
38. Properties of uridine-cytidine kinase derived from L1210 leukemia cells. Ahmed NK, Baker DR. Cancer Res; 1980 Oct 25; 40(10):3559-63. PubMed ID: 6254634 [Abstract] [Full Text] [Related]
39. Uptake and metabolism of N 5 -formyltetrahydrofolate by L1210 leukemia cells. Nahas A, Nixon PF, Bertino JR. Cancer Res; 1972 Jul 25; 32(7):1416-21. PubMed ID: 5030574 [No Abstract] [Full Text] [Related]
40. Deoxyguanosine-resistant leukemia L1210 cells. Loss of specific deoxyribonucleoside kinase activity. Cory AH, Shibley IA, Chalovich JM, Cory JG. J Biol Chem; 1993 Jan 05; 268(1):405-9. PubMed ID: 8380161 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]